scispace - formally typeset
K

Ko Bando

Researcher at University of Pittsburgh

Publications -  7
Citations -  735

Ko Bando is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Transplantation & Lung. The author has an hindex of 6, co-authored 7 publications receiving 722 citations.

Papers
More filters
Journal ArticleDOI

Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management

TL;DR: Recipients with obliterative bronchiolitis detected in the preclinical stage were significantly more likely to be in remission than recipients who had clinical disease at the time of diagnosis and results indicate that acute rejection is the most significant risk factor for development of obliteration and that obliteration responds to treatment with augmented immunosuppression when it is detected early by surveillance transbronchial biopsy.
Journal ArticleDOI

Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension.

TL;DR: Bilateral lung transplantation may be a more satisfactory option for patients with pulmonary hypertension with simple congenital heart disease, absent coronary arterial disease, and preserved left ventricular function.
Journal ArticleDOI

Impact of pulmonary hypertension on outcome after single-lung transplantation

TL;DR: Despite a shortage of donor organs, single-lung transplantation may be suboptimal therapy in patients with PH, and further study comparing single versus bilateral lung transplantation for PH is necessary.
Journal Article

Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease.

TL;DR: The results suggest that single lung transplantation is the procedure of choice for patients with nonseptic obstructive lung disease and the degree of pulmonary function improvement was better in single as compared with bilateral lung recipients.
Journal Article

Improved survival following pediatric cardiac transplantation in high-risk patients.

TL;DR: Although elevated transpulmonary gradient continues to be a significant risk factor for pediatric heart transplantation, candidates with congenital heart disease, UNOS status I, and pretransplant ECMO support now can be successfully transplanted with reasonable hope for extended survival.